PGDx Licenses Cell-free Tumor DNA Analysis Technology from Johns Hopkins | GenomeWeb

NEW YORK (GenomeWeb News) – Personal Genome Diagnostics today announced it has licensed the exclusive rights from Johns Hopkins University to a technology for analyzing cell-free tumor DNA circulating in blood.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.